BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2470544)

  • 1. High-molecular-mass proteins in haemodialysis-associated amyloidosis.
    Argiles A; Mourad G; Axelrud-Cavadore C; Watrin A; Mion C; Cavadore JC
    Clin Sci (Lond); 1989 May; 76(5):547-52. PubMed ID: 2470544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodialysis-associated amyloidosis: beta 2-microglobulin alone or associated with globin chains?
    Argiles A; Mourad G; Axelrud-Cavadore C; Derancourt J; Adell JJ; Mion C; Cavadore JC
    Clin Sci (Lond); 1987 Nov; 73(5):515-8. PubMed ID: 3315398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carpal tunnel syndrome caused by amyloid containing beta 2 microglobulin: a new amyloid and a complication of long term haemodialysis.
    McClure J; Bartley CJ; Ackrill P
    Ann Rheum Dis; 1986 Dec; 45(12):1007-11. PubMed ID: 3545104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amyloid deposits in hemodialysis patients: immunochemical analysis].
    Argiles A; Mourad G; Axelrud-Cavadore C; Cavadore JC; Mion C
    Nephrologie; 1987; 8(2):51-4. PubMed ID: 3302740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-2-microglobulin-associated amyloidosis in chronic hemodialysis patients with carpal tunnel syndrome.
    Ullian ME; Hammond WS; Alfrey AC; Schultz A; Molitoris BA
    Medicine (Baltimore); 1989 Mar; 68(2):107-15. PubMed ID: 2646507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 2-microglobulin: a new form of amyloid protein associated with chronic hemodialysis.
    Gejyo F; Odani S; Yamada T; Honma N; Saito H; Suzuki Y; Nakagawa Y; Kobayashi H; Maruyama Y; Hirasawa Y
    Kidney Int; 1986 Sep; 30(3):385-90. PubMed ID: 3537446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta 2-Microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term dialysis patients.
    Maury CP
    Rheumatol Int; 1990; 10(1):1-8. PubMed ID: 2191408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current clinical and pathogenetic understanding of beta2-m amyloidosis in long-term haemodialysis patients.
    Gejyo F; Narita I
    Nephrology (Carlton); 2003 Oct; 8 Suppl():S45-9. PubMed ID: 15012691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin.
    Gejyo F; Yamada T; Odani S; Nakagawa Y; Arakawa M; Kunitomo T; Kataoka H; Suzuki M; Hirasawa Y; Shirahama T
    Biochem Biophys Res Commun; 1985 Jun; 129(3):701-6. PubMed ID: 3893430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta 2-microglobulin amyloidosis (AB2M) in patients undergoing long-term hemodialysis. A new type of amyloid.
    Fuchs A; Jagirdar J; Schwartz IS
    Am J Clin Pathol; 1987 Sep; 88(3):302-7. PubMed ID: 3307375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monomeric and dimeric beta 2-microglobulin may be extracted from amyloid deposits in vitro.
    García-García M; Gouin-Charnet A; Mourad G; Argilés A
    Nephrol Dial Transplant; 1997 Jun; 12(6):1192-8. PubMed ID: 9198050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as beta 2-microglobulin.
    Shirahama T; Skinner M; Cohen AS; Gejyo F; Arakawa M; Suzuki M; Hirasawa Y
    Lab Invest; 1985 Dec; 53(6):705-9. PubMed ID: 2415776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of plasma proteinase inhibitors in beta 2-microglobulin amyloid deposits.
    Campistol JM; Shirahama T; Abraham CR; Rodgers OG; Solé M; Cohen AS; Skinner M
    Kidney Int; 1992 Oct; 42(4):915-23. PubMed ID: 1280700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dialysis amyloidosis and beta-2-microglobulin].
    Sulková S; Votruba T
    Cas Lek Cesk; 1989 Jan; 128(3):68-73. PubMed ID: 2655913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of amyloidosis: a role for anti-proteases?].
    Argilés i Ciscart A; Mourad G
    Nephrologie; 1991; 12(2):51-4. PubMed ID: 1719439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodialysis-associated amyloidosis and beta-2 microglobulin. Clinical and immunohistochemical study.
    Bardin T; Zingraff J; Shirahama T; Noel LH; Droz D; Voisin MC; Drueke T; Dryll A; Skinner M; Cohen AS
    Am J Med; 1987 Sep; 83(3):419-24. PubMed ID: 3310621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E and alpha 1-antichymotrypsin in dialysis-related amyloidosis.
    Gejyo F; Kimura H; Suzuki S; Miyazaki R; Naiki H; Nakakuki K
    Kidney Int Suppl; 1997 Nov; 62():S75-8. PubMed ID: 9350687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of beta-2 microglobulin and alpha-2 macroglobulin in kappa AL-amyloidosis.
    Argilés A; Bataille R; Mourad G; Demaille JG
    Nephrol Dial Transplant; 1992; 7(8):881-2. PubMed ID: 1381498
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic amyloidosis of beta 2-microglobulin type: a complication of long-term haemodialysis.
    Theaker JM; Raine AE; Rainey AJ; Heryet A; Clark A; Oliver DO
    J Clin Pathol; 1987 Oct; 40(10):1247-51. PubMed ID: 3119676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 2-macroglobulin protects some of the protein constituents of dialysis-associated amyloidosis from protease degradation.
    Gouin-Charnet A; Mourad G; Argilés A
    Biochem Biophys Res Commun; 1997 Feb; 231(1):48-51. PubMed ID: 9070217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.